Savitri Krishnamurthy, MD
Anatomic Pathology & Clinical Pathology · Houston, TXNPI 1194772988
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $70,063 of the $79,696 with a category attached, or 87.9%. AstraZeneca accounts for 87.9% of it on its own, with 1 other manufacturer making up the rest. Among anatomic pathology & clinical pathology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $1122.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$70K
- Roche Diagnostics Corporation$10K
What the payments were for
- Consulting fees$70,06388%
- Speaking & faculty fees$2,7233%
- Travel & lodging$6,1628%
- Food & beverage$7491%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 64 | $70,064 |
| Roche Diagnostics Corporation | 7 | $9,631 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enhertu$21,070
- MD cobas Instruments and Reagents$4,009
- CINtec PLUS Cytology$2,900
How this compares
$79,696 in reported general payments places this provider in the 95th percentile of 736 anatomic pathology & clinical pathology providers in Texas.
See all anatomic pathology & clinical pathology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Houston
- Rabia ShafiHouston$519K
- Jason GregorioHouston$238K
- Sanam LoghaviHouston$94K
- Thomas LohmannHouston$30K
- Aysegul SahinHouston$29K
- Lillian GaberHouston$23K
- Ken YoungHouston$23K
- Hong ZhangHouston$22K
- Michelle WilliamsHouston$12K
- Keyur PatelHouston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.